Saturday, April 2, 2022

Lilly, Incyte report positive results for baricitinib in alopecia areata

Eli Lilly and Incyte have reported positive results from two Phase III trials evaluating their oral JAK inhibitor baricitinib in alopecia areata (AA).

AA is an autoimmune condition that causes hair to fall out in small patches, with this hair loss affecting the scalp, face and sometimes other areas of the body.

There are currently no US Food and Drug Administration (FDA) approved therapies for the condition, Lilly and Incyte said in a statement.

In two studies – BRAVE-AA1 and BRAVE-AA2 – patients with severe AA were treated with either baricitinib 2 mg or 4 mg doses.

Results from the BRAVE-AA1 study showed that at week 36, the number of patients reaching 80% or more scalp hair coverage was 35% for those treated with baricitinib 4 mg, 22% for baricitinib 2 mg and 5% of patients in the placebo group.

Similarly in the BRAVE-AA2 study, at week 36 the proportion of patients reaching 80% or more scalp hair coverage was 33% for those receiving baricitinib 4 mg, 17% of patients treated with baricitinib 2 mg and 3% of patients in the placebo group.

The most common treatment-emergent adverse events in the two studies includes upper respiratory tract infections, headache and acne. The safety profile of baricitinib across both studies was consistent with the drug’s known safety profile in patients with rheumatoid arthritis (RA) and atopic dermatitis (AD).

“The positive results from our Phase III trials of baricitinib in alopecia areata bring us one step closer to potentially providing an approved treatment option to people affected by this serious autoimmune disease,” said Lotus Mallbris, vice president of immunology development at Lilly.

“We look forward to discussing with global regulators data from the BRAVE-AA clinical trial programme for this important potential treatment, which could be the first approved for people living with alopecia areata,” she added.

Source link

Latest Articles

Widely used chemical linked to 1,00,000 US deaths per year: Study

NEW YORK: Daily exposure to phthalates, a group of chemicals used in everything from plastic containers to makeup, may lead to approximately 100,000 deaths...

Foods to Reduce Inflammation and Strengthen the Immune System

Did you know that you can greatly reduce inflammation and boost your immune system by simply incorporating more anti-inflammatory foods and beverages into your...

Personal Selling

INTRODUCTION Early sellers and traders were not held in high esteem. The Roman word for salesman meant ‘Cheater’ and...

Building Muscle on a Vegan Diet

There are a lot of  misconceptions surrounding veganism. The notion that those who practice it are lacking in protein and therefore muscles is the...

Electrodes in brain new hope for severe cases of epilepsy

Neurosurgeons at All India Institute of Medical Sciences have devised a new technique for operating on children suffering from a severe form of epilepsy...